相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Greater improvement in LRRK2 G2019S patients undergoing Subthalamic Nucleus Deep Brain Stimulation compared to non-mutation carriers
Massiva Sayad et al.
BMC NEUROSCIENCE (2016)
Risk and course of motor complications in a population-based incident Parkinson's disease cohort
Anders Bjornestad et al.
PARKINSONISM & RELATED DISORDERS (2016)
Can the disease course in Parkinson's disease be slowed?
Amos D. Korczyn et al.
BMC MEDICINE (2015)
Freezing of gait: a practical approach to management
Jorik Nonnekes et al.
LANCET NEUROLOGY (2015)
REM Sleep Behavior Disorder, as Assessed by Questionnaire, in G2019S LRRK2 Mutation PD and Carriers
Rachel Saunders-Pullman et al.
MOVEMENT DISORDERS (2015)
New Treatments for Levodopa-Induced Motor Complications
Olivier Rascol et al.
MOVEMENT DISORDERS (2015)
Cognitive Profile of LRRK2-Related Parkinson's Disease
Sindhu Srivatsal et al.
MOVEMENT DISORDERS (2015)
MDS clinical diagnostic criteria for Parkinson's disease
Ronald B. Postuma et al.
MOVEMENT DISORDERS (2015)
Impact of glucocerebrosidase mutations on motor and nonmotor complications in Parkinson's disease
Tomoko Oeda et al.
NEUROBIOLOGY OF AGING (2015)
Age-specific penetrance of LRRK2 G2019S in the Michael J. Fox Ashkenazi Jewish LRRK2 Consortium
Karen Marder et al.
NEUROLOGY (2015)
Differential effects of severe vs mild GBA mutations on Parkinson disease
Ziv Gan-Or et al.
NEUROLOGY (2015)
Measuring the burden and mortality of hospitalisation in Parkinson's disease: A cross-sectional analysis of the English Hospital Episodes Statistics database 2009-2013
Vincent Low et al.
PARKINSONISM & RELATED DISORDERS (2015)
Cognitive and behavioral symptoms in Parkinson's disease patients with the G2019S and R1441G mutations of the LRRK2 gene
Johanne Hatteland Somme et al.
PARKINSONISM & RELATED DISORDERS (2015)
Neuropsychological performance in LRRK2 G2019S carriers with Parkinson's disease
Roy N. Alcalay et al.
PARKINSONISM & RELATED DISORDERS (2015)
Differential effect of caffeine intake in subjects with genetic susceptibility to Parkinson's Disease
Prakash M. Kumar et al.
SCIENTIFIC REPORTS (2015)
Parkinson's Disease Subtypes in the Oxford Parkinson Disease Centre (OPDC) Discovery Cohort
Michael Lawton et al.
JOURNAL OF PARKINSONS DISEASE (2015)
Evolution of Prodromal Clinical Markers of Parkinson Disease in a GBA Mutation-Positive Cohort
Michelle Beavan et al.
JAMA NEUROLOGY (2015)
Sleep Disorders in Parkinsonian and Nonparkinsonian LRRK2 Mutation Carriers
Claustre Pont-Sunyer et al.
PLOS ONE (2015)
GBA mutations are associated with Rapid Eye Movement Sleep Behavior Disorder
Ziv Gan-Or et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2015)
Visual short-term memory deficits associated with GBA mutation and Parkinson's disease
Nahid Zokaei et al.
BRAIN (2014)
Ambroxol improves lysosomal biochemistry in glucocerebrosidase mutation-linked Parkinson disease cells
Alisdair McNeill et al.
BRAIN (2014)
Genetic analysis implicates APOE, SNCA and suggests lysosomal dysfunction in the etiology of dementia with Lewy bodies
Jose Bras et al.
HUMAN MOLECULAR GENETICS (2014)
Pharmacological Treatment of Parkinson Disease A Review
Barbara S. Connolly et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
Cognitive impairment and dementia in Parkinson's disease: Practical issues and management
Murat Emre et al.
MOVEMENT DISORDERS (2014)
Clinical profiles of Parkinson's disease associated with common leucine-rich repeat kinase 2 and glucocerebrosidase genetic variants in Chinese individuals
Chaodong Wang et al.
NEUROBIOLOGY OF AGING (2014)
Disease Penetrance of Late-Onset Parkinsonism A Meta-analysis
Joanne Trinh et al.
JAMA NEUROLOGY (2014)
Olfactory identification in LRRK2 G2019S mutation carriers: a relevant marker?
Rachel Saunders-Pullman et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2014)
Genotype and Phenotype in Parkinson's Disease: Lessons in Heterogeneity From Deep Brain Stimulation
Aikaterina Angeli et al.
MOVEMENT DISORDERS (2013)
Parkinson Disease Phenotype in Ashkenazi Jews With and Without LRRK2 G2019S Mutations
Roy N. Alcalay et al.
MOVEMENT DISORDERS (2013)
Fall Risk and Gait in Parkinson's Disease: The Role of the LRRK2 G2019S Mutation
Anat Mirelman et al.
MOVEMENT DISORDERS (2013)
The LRRK2 G2019S mutation status does not affect the outcome of subthalamic stimulation in patients with Parkinson's disease
Lior Greenbaum et al.
PARKINSONISM & RELATED DISORDERS (2013)
Autonomic dysfunction in parkinsonian LRRK2 mutation carriers
Beatriz Tijero et al.
PARKINSONISM & RELATED DISORDERS (2013)
Association of Sequence Alterations in the Putative Promoter of RAB7L1 With a Reduced Parkinson Disease Risk
Ziv Gan-Or et al.
ARCHIVES OF NEUROLOGY (2012)
Emerging therapies for Parkinson's disease
Werner Poewe et al.
CURRENT OPINION IN NEUROLOGY (2012)
The Age at Motor Symptoms Onset in LRRK2-Associated Parkinson's Disease is Affected by a Variation in the MAPT Locus: A Possible Interaction
Ziv Gan-Or et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2012)
A clinical and family history study of Parkinson's disease in heterozygous glucocerebrosidase mutation carriers
Alisdair McNeill et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2012)
Cognitive performance of GBA mutation carriers with early-onset PD The CORE-PD study
R. N. Alcalay et al.
NEUROLOGY (2012)
Cognitive dysfunction in Tunisian LRRK2 associated Parkinson's disease
Samia Ben Sassi et al.
PARKINSONISM & RELATED DISORDERS (2012)
Dyskinesias in patients with Parkinson's disease: Effect of the leucine-rich repeat kinase 2 (LRRK2) G2019S mutation
Gilad Yahalom et al.
PARKINSONISM & RELATED DISORDERS (2012)
Large-scale screening of the Gaucher's disease-related glucocerebrosidase gene in Europeans with Parkinson's disease
Suzanne Lesage et al.
HUMAN MOLECULAR GENETICS (2011)
Clinical Subtypes of Parkinson's Disease
Stephanie M. van Rooden et al.
MOVEMENT DISORDERS (2011)
The Motor Phenotype of Parkinson's Disease in Relation to Age at Onset
Mirdhu M. Wickremaratchi et al.
MOVEMENT DISORDERS (2011)
GBA-associated PD presents with nonmotor characteristics
K. Brockmann et al.
NEUROLOGY (2011)
Phenotype in parkinsonian and nonparkinsonian LRRK2 G2019S mutation carriers
C. Marras et al.
NEUROLOGY (2011)
Dopamine-Induced Nonmotor Symptoms of Parkinson's Disease
Ariane Park et al.
PARKINSONS DISEASE (2011)
Self-report of cognitive impairment and mini-mental state examination performance in PRKN, LRRK2, and GBA carriers with early onset Parkinson's disease
Roy N. Alcalay et al.
JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY (2010)
Gaucher Disease Ascertained Through a Parkinson's Center: Imaging and Clinical Characterization
Rachel Saunders-Pullman et al.
MOVEMENT DISORDERS (2010)
Mitochondrial impairment in patients with Parkinson disease with the G2019S mutation in LRRK2
Heather Mortiboys et al.
NEUROLOGY (2010)
A meta-regression of the long-term effects of deep brain stimulation on balance and gait in PD
R. J. St. George et al.
NEUROLOGY (2010)
LRRK2 G2019S mutation in Parkinson's disease: A neuropsychological and neuropsychiatric study in a large Algerian cohort
Soreya Belarbi et al.
PARKINSONISM & RELATED DISORDERS (2010)
A clinico-pathological study of subtypes in Parkinson's disease
M. Selikhova et al.
BRAIN (2009)
The LRRK2 G2019S mutation as the cause of Parkinson's disease in Ashkenazi Jews
Avner Thaler et al.
JOURNAL OF NEURAL TRANSMISSION (2009)
Genotype-phenotype correlations between GBA mutations and Parkinson disease risk and onset
Z. Gan-Or et al.
NEUROLOGY (2008)
LRRK2 G2019S mutation and Parkinson's disease: A clinical, neuropsychological and neuropsychiatric study in a large Italian sample
Stefano Goldwurm et al.
PARKINSONISM & RELATED DISORDERS (2006)
Falls and freezing of gait in Parkinson's disease: A review of two interconnected, episodic phenomena
BR Bloem et al.
MOVEMENT DISORDERS (2004)
Functional decline in Parkinson disease
J Jankovic et al.
ARCHIVES OF NEUROLOGY (2001)